Outpatient Management of Skin and Soft Tissue Infections Associated With Community-Associated Methicillin-Resistant Staphylococcus Aureus: An Evidence-Based Approach

Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has recently been identified as the predominant causative bacterium for skin and soft tissue infections (SSTIs) in outpatient and emergency department patients. Given the increasing prevalence of CA-MRSA related to SSTIs, appropriate decisions based on evidence-based guidelines are essential in successful treatment. It is imperative for clinicians to stay informed about the epidemiological and treatment of emerging organisms in order to positively influence patient outcomes and eliminate the unnecessary use of antibiotics.